PRF Technologies (PRFX) Interest Coverage Ratio (2020 - 2023)
PRF Technologies (PRFX) posted quarterly Interest Coverage Ratio of 0.51 for Q4 2023, up 15.02% year-on-year from 0.45 in Q4 2022, and up 15.02% on a QoQ basis from 0.61 in Q4 2022.
PRF Technologies (PRFX) Interest Coverage Ratio (2020 - 2023) Analysis & Trends
PRF Technologies (PRFX) has reported Interest Coverage Ratio for 4 consecutive years, with 0.51 the latest figure, recorded in Q4 2023.
- Quarterly Interest Coverage Ratio rose 15.02% year-over-year to 0.51 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was 1.38 (up 16.11% YoY) and the FY2025 annual result came in at 0.39, up 72.95% from the prior year.
- Interest Coverage Ratio climbed to 0.51 in Q4 2023 per PRFX's latest filing, from 0.61 in the prior quarter.
- Over the last five years, Interest Coverage Ratio for PRFX reached as high as 0.2 in Q4 2020 and fell as low as 0.61 in Q4 2022.
- A 4-year average of 0.42 and a median of 0.43 in 2023 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2021 — Interest Coverage Ratio plunged 78.08% — and 2023, when it increased 15.02%.
- Year by year, Interest Coverage Ratio stood at 0.2 in 2020, then tumbled by 78.08% to 0.35 in 2021, then slumped by 71.09% to 0.61 in 2022, then gained by 15.02% to 0.51 in 2023.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 0.51, 0.61, and 0.35 for Q4 2023, Q4 2022, and Q4 2021 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 13.44 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.81 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.18 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -0.07 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.33 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.11 |
| 10 | PRF Technologies | 745,168.93 | 451,168.93 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -0.51 |
| Dec 31, 2022 | -0.61 |
| Dec 31, 2021 | -0.35 |
| Dec 31, 2020 | -0.20 |